{"id":458559,"date":"2021-03-16T08:08:05","date_gmt":"2021-03-16T12:08:05","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=458559"},"modified":"2021-03-16T08:08:05","modified_gmt":"2021-03-16T12:08:05","slug":"imagin-medical-reports-manufacturing-progess","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/","title":{"rendered":"IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">VANCOUVER, B.C. \/ BOSTON, March  16, 2021  (GLOBE NEWSWIRE) &#8212; via InvestorWire \u2013 Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt &amp; Stuttgart Symbol: DPD2) (\u201cImagin\u201d or the \u201cCompany\u201d) today reported continued progress towards commercial-stage manufacturing capability with Lighthouse Imaging (\u201cLighthouse\u201d).<\/p>\n<p align=\"justify\">Prior to Imagin\u2019s selection of Lighthouse as its contract manufacturer for the i\/Blue Imaging System\u2122 in October 2020, the Company received multiple fully functional feasibility units from its original design partner, Optel, Inc. Lighthouse\u2019s development program has since focused on further refining the design to support Imagin\u2019s submissions to the U.S. Food and Drug Administration and to ensure final device performance, compliance with all applicable regulatory standards, and optimal manufacturability to meet both cost targets and anticipated user demand. <\/p>\n<p align=\"justify\">\u201cWe chose Lighthouse because of its accomplished history of taking innovative products like our i\/Blue System and applying its cross-functional expertise in optics, electronics, software and mechanical design to move into commercial manufacturing,\u201d commented Mike Vergano, Imagin\u2019s Director of Engineering and Quality. \u201cWe have not been disappointed. The Lighthouse team\u2019s work to-date has been exceptional, and we look forward to that continuing.\u201d<\/p>\n<p align=\"justify\">\u201cAs previously reported, the impact of the COVID-19 pandemic in 2020 altered our product timeline by approximately nine months, moving expected completion into 2022,\u201d said Jim Hutchens, Imagin\u2019s President and CEO. \u201cThe good news is that Lighthouse\u2019s program has stayed on schedule and we expect it to remain on target going forward.\u201d<\/p>\n<p align=\"justify\">\n        <strong>About Imagin Medical<\/strong><br \/>\n        <br \/>Imagin Medical is a surgical imaging company focused on advancing new methods of visualizing cancer during minimally invasive procedures. The Company believes its first product, the i\/Blue\u2122 Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting cancer for removal, helping to reduce recurrence rates. The Company\u2019s initial focus is bladder cancer. Learn more at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oLlfI5Ijo9nL_QoXq3rtgqCcEhQIkc2g8ByE_GtGR4ifWoNo7bpPaBSXyX-agwz8EFz2klLuPklRcTGok5d4zaMwSMjTQctdAyHcDzce1ek=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.imaginmedical.com<\/u>.<\/a><\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <em>Forward-Looking Statements<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <em>Information set forth in this news release contains forward-looking statements. These statements reflect management\u2019s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward- looking statements are inherently uncertain, and that actual performance may be affected by a number of material factors, many of which are beyond the Company\u2019s control. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Specifically, there is no assurance the Company\u2019s imaging system will work in the manner expected. \u00a0Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information. The CSE has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.<\/em>\n      <\/p>\n<p align=\"left\">\n        <b><br \/>\n          <b>Contact:<\/b><br \/>\n        <\/b>\n      <\/p>\n<p>Jim Hutchens<br \/>President &amp; CEO <br \/>Telephone: 833-246-2446<\/p>\n<p>\n        <strong>Corporate Communications:<\/strong><br \/>\n        <br \/>InvestorBrandNetwork (IBN)<br \/> Los Angeles, California<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VvBBR4vuSFEbYOo_-tPiA7wY6KW0yNCN5nnSPZejvThK-Be7uSssAE2_fA4PmnbPfhq_i9VmZ3Jbkjaa5ia2eZfR723hFDABcI9_4l7NBL_IMafPEKxVffYyXrxxezZa\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.InvestorBrandNetwork.com<\/u><\/a><br \/> 310.299.1717 Office<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FGgm1EJYQGVT294h3gm0-_Li1meIh1gtCOczSnBL0O1jJV_h40d7pm1LkFeEq6ckwzMBr_G0ku5z2VnqyvB2U4PUfvWjFr7RQpV14Mlc8llmw_ihICNGcgK2_stUpefU6KZmGK5HqMYlF0cPuLczYjoS2eigkQzS0H4SUSJMng9GFvC7rKLSgDtkDHT4d6xoeg-ZQEz07uDAxEObqkw5LxIuuwO5cZwtIJ1P2sLJfjAetbjixywXMz1OnsU0CLcT0_B2sVyH1fJtwmCZgex3cNPUp3ygIGj1i0K1rWmJwN0=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Editor@InvestorBrandNetwork.com<\/u><\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4OTg0NyM0MDYzNzQ3IzUwMDA3Njk1NQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/86a13498-f233-460f-85e6-dd13e2014e5a\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>VANCOUVER, B.C. \/ BOSTON, March 16, 2021 (GLOBE NEWSWIRE) &#8212; via InvestorWire \u2013 Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt &amp; Stuttgart Symbol: DPD2) (\u201cImagin\u201d or the \u201cCompany\u201d) today reported continued progress towards commercial-stage manufacturing capability with Lighthouse Imaging (\u201cLighthouse\u201d). Prior to Imagin\u2019s selection of Lighthouse as its contract manufacturer for the i\/Blue Imaging System\u2122 in October 2020, the Company received multiple fully functional feasibility units from its original design partner, Optel, Inc. Lighthouse\u2019s development program has since focused on further refining the design to support Imagin\u2019s submissions to the U.S. Food and Drug Administration and to ensure final device performance, compliance with all applicable regulatory standards, and optimal manufacturability to meet both cost targets and anticipated user demand. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-458559","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, B.C. \/ BOSTON, March 16, 2021 (GLOBE NEWSWIRE) &#8212; via InvestorWire \u2013 Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt &amp; Stuttgart Symbol: DPD2) (\u201cImagin\u201d or the \u201cCompany\u201d) today reported continued progress towards commercial-stage manufacturing capability with Lighthouse Imaging (\u201cLighthouse\u201d). Prior to Imagin\u2019s selection of Lighthouse as its contract manufacturer for the i\/Blue Imaging System\u2122 in October 2020, the Company received multiple fully functional feasibility units from its original design partner, Optel, Inc. Lighthouse\u2019s development program has since focused on further refining the design to support Imagin\u2019s submissions to the U.S. Food and Drug Administration and to ensure final device performance, compliance with all applicable regulatory standards, and optimal manufacturability to meet both cost targets and anticipated user demand. &hellip; Continue reading &quot;IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-16T12:08:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4OTg0NyM0MDYzNzQ3IzUwMDA3Njk1NQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagin-medical-reports-manufacturing-progess\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagin-medical-reports-manufacturing-progess\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS\",\"datePublished\":\"2021-03-16T12:08:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagin-medical-reports-manufacturing-progess\\\/\"},\"wordCount\":484,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagin-medical-reports-manufacturing-progess\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4OTg0NyM0MDYzNzQ3IzUwMDA3Njk1NQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagin-medical-reports-manufacturing-progess\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagin-medical-reports-manufacturing-progess\\\/\",\"name\":\"IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagin-medical-reports-manufacturing-progess\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagin-medical-reports-manufacturing-progess\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4OTg0NyM0MDYzNzQ3IzUwMDA3Njk1NQ==\",\"datePublished\":\"2021-03-16T12:08:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagin-medical-reports-manufacturing-progess\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagin-medical-reports-manufacturing-progess\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagin-medical-reports-manufacturing-progess\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4OTg0NyM0MDYzNzQ3IzUwMDA3Njk1NQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4OTg0NyM0MDYzNzQ3IzUwMDA3Njk1NQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/imagin-medical-reports-manufacturing-progess\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/","og_locale":"en_US","og_type":"article","og_title":"IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS - Market Newsdesk","og_description":"VANCOUVER, B.C. \/ BOSTON, March 16, 2021 (GLOBE NEWSWIRE) &#8212; via InvestorWire \u2013 Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt &amp; Stuttgart Symbol: DPD2) (\u201cImagin\u201d or the \u201cCompany\u201d) today reported continued progress towards commercial-stage manufacturing capability with Lighthouse Imaging (\u201cLighthouse\u201d). Prior to Imagin\u2019s selection of Lighthouse as its contract manufacturer for the i\/Blue Imaging System\u2122 in October 2020, the Company received multiple fully functional feasibility units from its original design partner, Optel, Inc. Lighthouse\u2019s development program has since focused on further refining the design to support Imagin\u2019s submissions to the U.S. Food and Drug Administration and to ensure final device performance, compliance with all applicable regulatory standards, and optimal manufacturability to meet both cost targets and anticipated user demand. &hellip; Continue reading \"IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-16T12:08:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4OTg0NyM0MDYzNzQ3IzUwMDA3Njk1NQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS","datePublished":"2021-03-16T12:08:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/"},"wordCount":484,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4OTg0NyM0MDYzNzQ3IzUwMDA3Njk1NQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/","name":"IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4OTg0NyM0MDYzNzQ3IzUwMDA3Njk1NQ==","datePublished":"2021-03-16T12:08:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4OTg0NyM0MDYzNzQ3IzUwMDA3Njk1NQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4OTg0NyM0MDYzNzQ3IzUwMDA3Njk1NQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/458559","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=458559"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/458559\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=458559"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=458559"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=458559"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}